I propose to take Questions Nos. 233 to 235, inclusive, together.
Nadolol was being reimbursed by the HSE at a price of €79.45. The supplier informed the HSE some months ago that it could not continue to supply at that price. The HSE is aware that the price currently offered to community pharmacies is in the region of €259. Where there is a sudden increase in price sought under the Drug Payment Scheme, there is an onus on the HSE to establish the reasonableness and accuracy of the claim. While this may result in a delay, the HSE makes every effort to expedite the process.
It is not possible to guarantee that there will no supply issues in relation to any individual drug; however the HSE strives to ensure continuity of supply.